 |
Prescription and Over-the-Counter Drug Product List
23rd Edition
Cumulative Supplement Number 5: May 2004
NOTE: The format for the Monthly Additions/Deletions Drug
Product List has changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.5
CUMULATIVE SUPPLEMENT LEGEND.
TABLET; ORAL
DARVOCET A500
>D> + AAIPHARMA 500MG;100MG N76429 001 Sep 10, 2003 Ma CRLD
>A> 500MG;100MG N76429 001 Sep 10, 2003 Ma CRLD
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
>A> VINTAGE PHARMS 325MG;100MG N76743 001 May 07, 2004 Ma NEWA
ACETAZOLAMIDE SODIUM
INJECTABLE; INJECTION
ACETAZOLAMIDE SODIUM
>D> AP ABBOTT EQ 500MG BASE/VIAL N40108 001 Oct 30, 1995 Ma CAHN
>A> AP HOSPIRA EQ 500MG BASE/VIAL N40108 001 Oct 30, 1995 Ma CAHN
ACETIC ACID, GLACIAL
SOLUTION; IRRIGATION, URETHRAL
ACETIC ACID 0.25% IN PLASTIC CONTAINER
>D> AT ABBOTT 250MG/100ML N17656 001 Ma CAHN
>A> AT HOSPIRA 250MG/100ML N17656 001 Ma CAHN
ACETYLCYSTEINE
SOLUTION; INHALATION, ORAL
ACETYLCYSTEINE
>D> AN ABBOTT 10% N73664 001 Aug 30, 1994 Ma CAHN
>D> AN 20% N74037 001 Aug 30, 1994 Ma CAHN
>A> AN HOSPIRA 10% N73664 001 Aug 30, 1994 Ma CAHN
>A> AN 20% N74037 001 Aug 30, 1994 Ma CAHN
ACYCLOVIR SODIUM
INJECTABLE; INJECTION
ACYCLOVIR SODIUM
>D> AP ABBOTT EQ 500MG BASE/VIAL N74758 001 Apr 22, 1997 Ma CAHN
>D> AP EQ 500MG BASE/VIAL N74663 001 Apr 22, 1997 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N74758 002 Apr 22, 1997 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N74663 002 Apr 22, 1997 Ma CAHN
>A> AP HOSPIRA EQ 500MG BASE/VIAL N74758 001 Apr 22, 1997 Ma CAHN
>A> AP EQ 500MG BASE/VIAL N74663 001 Apr 22, 1997 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N74758 002 Apr 22, 1997 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N74663 002 Apr 22, 1997 Ma CAHN
ALCOHOL; DEXTROSE
INJECTABLE; INJECTION
ALCOHOL 5% IN D5-W
>D> AP ABBOTT 5ML/100ML;5GM/100ML N83263 001 Ma CAHN
>A> AP HOSPIRA 5ML/100ML;5GM/100ML N83263 001 Ma CAHN
ALFENTANIL HYDROCHLORIDE
INJECTABLE; INJECTION
ALFENTANIL
>D> AP ABBOTT EQ 0.5MG BASE/ML N75221 001 Oct 28, 1999 Ma CAHN
>A> AP HOSPIRA EQ 0.5MG BASE/ML N75221 001 Oct 28, 1999 Ma CAHN
AMIKACIN SULFATE
INJECTABLE; INJECTION
AMIKACIN SULFATE
>D> AP ABBOTT EQ 50MG BASE/ML N63263 001 Nov 30, 1994 Ma CAHN
>D> EQ 62.5MG BASE/ML N63283 001 Oct 31, 1994 Ma CAHN
>D> @ EQ 250MG BASE/ML N64099 001 Jun 20, 1995 Ma CAHN
>D> AP EQ 250MG BASE/ML N64098 001 Jun 26, 1995 Ma CAHN
>D> AP EQ 250MG BASE/ML N63264 001 Nov 30, 1994 Ma CAHN
>A> AP HOSPIRA EQ 50MG BASE/ML N63263 001 Nov 30, 1994 Ma CAHN
>A> EQ 62.5MG BASE/ML N63283 001 Oct 31, 1994 Ma CAHN
>A> @ EQ 250MG BASE/ML N64099 001 Jun 20, 1995 Ma CAHN
>A> AP HOSPIRA EQ 250MG BASE/ML N64098 001 Jun 26, 1995 Ma CAHN
>A> AP EQ 250MG BASE/ML N63264 001 Nov 30, 1994 Ma CAHN
AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> ABBOTT EQ 500MG BASE/100ML N64146 001 Apr 02, 1997 Ma CAHN
>A> HOSPIRA EQ 500MG BASE/100ML N64146 001 Apr 02, 1997 Ma CAHN
AMINO ACIDS
INJECTABLE; INJECTION
AMINOSYN 10%
>D> ABBOTT 10% (10GM/100ML) N17673 003 Ma CAHN
>A> HOSPIRA 10% (10GM/100ML) N17673 003 Ma CAHN
AMINOSYN 10% (PH6)
>D> ABBOTT 10% (10GM/100ML) N17673 008 Nov 18, 1985 Ma CAHN
>A> HOSPIRA 10% (10GM/100ML) N17673 008 Nov 18, 1985 Ma CAHN
AMINOSYN 3.5%
>D> ABBOTT 3.5% (3.5GM/100ML) N17789 004 Ma CAHN
>A> HOSPIRA 3.5% (3.5GM/100ML) N17789 004 Ma CAHN
AMINOSYN 5%
>D> ABBOTT 5% (5GM/100ML) N17673 001 Ma CAHN
>A> HOSPIRA 5% (5GM/100ML) N17673 001 Ma CAHN
AMINOSYN 7%
>D> @ ABBOTT 7% (7GM/100ML) N17673 002 Ma CAHN
>A> @ HOSPIRA 7% (7GM/100ML) N17673 002 Ma CAHN
AMINOSYN 7% (PH6)
>D> ABBOTT 7% (7GM/100ML) N17673 006 Nov 18, 1985 Ma CAHN
>A> HOSPIRA 7% (7GM/100ML) N17673 006 Nov 18, 1985 Ma CAHN
AMINOSYN 8.5%
>D> @ ABBOTT 8.5% (8.5GM/100ML) N17673 004 Ma CAHN
>A> @ HOSPIRA 8.5% (8.5GM/100ML) N17673 004 Ma CAHN
AMINOSYN 8.5% (PH6)
>D> ABBOTT 8.5% (8.5GM/100ML) N17673 007 Nov 18, 1985 Ma CAHN
>A> HOSPIRA 8.5% (8.5GM/100ML) N17673 007 Nov 18, 1985 Ma CAHN
AMINOSYN II 10%
>D> ABBOTT 10% (10GM/100ML) N19438 005 Apr 03, 1986 Ma CAHN
>A> HOSPIRA 10% (10GM/100ML) N19438 005 Apr 03, 1986 Ma CAHN
AMINOSYN II 10% IN PLASTIC CONTAINER
>D> ABBOTT 10% (10GM/100ML) N20015 001 Dec 19, 1991 Ma CAHN
>A> HOSPIRA 10% (10GM/100ML) N20015 001 Dec 19, 1991 Ma CAHN
AMINOSYN II 15% IN PLASTIC CONTAINER
>D> ABBOTT 15% (15GM/100ML) N20041 001 Dec 19, 1991 Ma CAHN
>A> HOSPIRA 15% (15GM/100ML) N20041 001 Dec 19, 1991 Ma CAHN
AMINOSYN II 3.5%
>D> @ ABBOTT 3.5% (3.5GM/100ML) N19438 001 Apr 03, 1986 Ma CAHN
>A> @ HOSPIRA 3.5% (3.5GM/100ML) N19438 001 Apr 03, 1986 Ma CAHN
AMINOSYN II 5%
>D> @ ABBOTT 5% (5GM/100ML) N19438 002 Apr 03, 1986 Ma CAHN
>A> @ HOSPIRA 5% (5GM/100ML) N19438 002 Apr 03, 1986 Ma CAHN
AMINOSYN II 7%
>D> ABBOTT 7% (7GM/100ML) N19438 003 Apr 03, 1986 Ma CAHN
>A> HOSPIRA 7% (7GM/100ML) N19438 003 Apr 03, 1986 Ma CAHN
AMINOSYN II 8.5%
>D> ABBOTT 8.5% (8.5GM/100ML) N19438 004 Apr 03, 1986 Ma CAHN
>A> HOSPIRA 8.5% (8.5GM/100ML) N19438 004 Apr 03, 1986 Ma CAHN
AMINOSYN-HBC 7%
>D> ABBOTT 7% (7GM/100ML) N19374 001 Jul 12, 1985 Ma CAHN
>A> HOSPIRA 7% (7GM/100ML) N19374 001 Jul 12, 1985 Ma CAHN
AMINOSYN-HF 8%
>D> ABBOTT 8% (8GM/100ML) N20345 001 Apr 04, 1996 Ma CAHN
>A> HOSPIRA 8% (8GM/100ML) N20345 001 Apr 04, 1996 Ma CAHN
AMINOSYN-PF 10%
>D> ABBOTT 10% (10GM/100ML) N19492 002 Oct 17, 1986 Ma CAHN
>A> HOSPIRA 10% (10GM/100ML) N19492 002 Oct 17, 1986 Ma CAHN
AMINOSYN-PF 7%
>D> ABBOTT 7% (7GM/100ML) N19398 001 Sep 06, 1985 Ma CAHN
>A> HOSPIRA 7% (7GM/100ML) N19398 001 Sep 06, 1985 Ma CAHN
AMINOSYN-RF 5.2%
>D> ABBOTT 5.2% (5.2GM/100ML) N18429 001 Ma CAHN
>A> HOSPIRA 5.2% (5.2GM/100ML) N18429 001 Ma CAHN
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE;
INJECTABLE; INJECTION
AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
>D> ABBOTT 3.5%;36.8MG/100ML;25GM/100ML;51MG N19683 001 Nov 07, 1988 Ma CAHN
/100ML;22.4MG/100ML;261MG/100ML;20
>A> HOSPIRA 3.5%;36.8MG/100ML;25GM/100ML;51MG N19683 001 Nov 07, 1988 Ma CAHN
/100ML;22.4MG/100ML;261MG/100ML;20
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER
>D> ABBOTT 4.25%;36.8MG/100ML;20GM/100ML;51M N19683 002 Nov 07, 1988 Ma CAHN
G/100ML;22.4MG/100ML;261MG/100ML;2
05MG/100ML
>A> HOSPIRA 4.25%;36.8MG/100ML;20GM/100ML;51M N19683 002 Nov 07, 1988 Ma CAHN
G/100ML;22.4MG/100ML;261MG/100ML;2
05MG/100ML
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
>D> ABBOTT 4.25%;36.8MG/100ML;25GM/100ML;51M N19683 003 Nov 07, 1988 Ma CAHN
G/100ML;22.4MG/100ML;261MG/100ML;2
05MG/100ML
>A> HOSPIRA 4.25%;36.8MG/100ML;25GM/100ML;51M N19683 003 Nov 07, 1988 Ma CAHN
G/100ML;22.4MG/100ML;261MG/100ML;2
05MG/100ML
AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER
>D> @ ABBOTT 5%;36.8MG/100ML;25GM/100ML;51MG/1 N19683 004 Nov 07, 1988 Ma CAHN
00ML;22.4MG/100ML;261MG/100ML;205
>A> @ HOSPIRA 5%;36.8MG/100ML;25GM/100ML;51MG/1 N19683 004 Nov 07, 1988 Ma CAHN
00ML;22.4MG/100ML;261MG/100ML;205
AMINO ACIDS; DEXTROSE
INJECTABLE; INJECTION
AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER
>D> ABBOTT 3.5%;25GM/100ML N19681 001 Nov 01, 1988 Ma CAHN
>A> HOSPIRA 3.5%;25GM/100ML N19681 001 Nov 01, 1988 Ma CAHN
AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 3.5%;5GM/100ML N19681 002 Nov 01, 1988 Ma CAHN
>A> HOSPIRA 3.5%;5GM/100ML N19681 002 Nov 01, 1988 Ma CAHN
AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER
>D> ABBOTT 4.25%;10GM/100ML N19681 004 Nov 01, 1988 Ma CAHN
>A> HOSPIRA 4.25%;10GM/100ML N19681 004 Nov 01, 1988 Ma CAHN
AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
>D> ABBOTT 4.25%;20GM/100ML N19681 005 Nov 01, 1988 Ma CAHN
>A> HOSPIRA 4.25%;20GM/100ML N19681 005 Nov 01, 1988 Ma CAHN
AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
>D> ABBOTT 4.25%;25GM/100ML N19681 003 Nov 01, 1988 Ma CAHN
>A> HOSPIRA 4.25%;25GM/100ML N19681 003 Nov 01, 1988 Ma CAHN
AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER
>D> ABBOTT 5%;25GM/100ML N19681 006 Nov 01, 1988 Ma CAHN
>A> HOSPIRA 5%;25GM/100ML N19681 006 Nov 01, 1988 Ma CAHN
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE;
INJECTABLE; INJECTION
AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC
>D> @ ABBOTT 4.25%;10GM/100ML;51MG/100ML;176.5 N19682 003 Nov 01, 1988 Ma CAHN
MG/100ML;22.4MG/100ML;104.5MG/100
ML;205MG/100ML
>A> @ HOSPIRA 4.25%;10GM/100ML;51MG/100ML;176.5 N19682 003 Nov 01, 1988 Ma CAHN
MG/100ML;22.4MG/100ML;104.5MG/100
ML;205MG/100ML
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE;
INJECTABLE; INJECTION
AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 3.5%;5GM/100ML;30MG/100ML;97MG/10 N19682 001 Nov 01, 1988 Ma CAHN
0ML;120MG/100ML;49.3MG/100ML
>A> HOSPIRA 3.5%;5GM/100ML;30MG/100ML;97MG/10 N19682 001 Nov 01, 1988 Ma CAHN
0ML;120MG/100ML;49.3MG/100ML
AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER
>D> ABBOTT 4.25%;5GM/100ML;30MG/100ML;97MG/1 N19682 002 Nov 01, 1988 Ma CAHN
00ML;120MG/100ML;49.3MG/100ML
>A> HOSPIRA 4.25%;5GM/100ML;30MG/100ML;97MG/1 N19682 002 Nov 01, 1988 Ma CAHN
00ML;120MG/100ML;49.3MG/100ML
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; SODIUM
INJECTABLE; INJECTION
AMINOSYN 3.5% M
>D> ABBOTT 3.5%;21MG/100ML;40MG/100ML;128MG/ N17789 003 Ma CAHN
100ML;234MG/100ML
>A> HOSPIRA 3.5%;21MG/100ML;40MG/100ML;128MG/ N17789 003 Ma CAHN
100ML;234MG/100ML
AMINO ACIDS; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
AMINOSYN 3.5% M
>D> @ ABBOTT 3.5%;21MG/100ML;128MG/100ML;234M N17789 005 Ma CAHN
G/100ML
>A> @ HOSPIRA 3.5%;21MG/100ML;128MG/100ML;234M N17789 005 Ma CAHN
G/100ML
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC;
INJECTABLE; INJECTION
AMINOSYN II 10% W/ ELECTROLYTES
>D> ABBOTT 10%;102MG/100ML;45MG/100ML;522MG N19437 004 Apr 03, 1986 Ma CAHN
/100ML;410MG/100ML
>A> HOSPIRA 10%;102MG/100ML;45MG/100ML;522MG N19437 004 Apr 03, 1986 Ma CAHN
/100ML;410MG/100ML
AMINOSYN II 7% W/ ELECTROLYTES
>D> @ ABBOTT 7%;102MG/100ML;45MG/100ML;522MG/ N19437 006 Apr 03, 1986 Ma CAHN
100ML;410MG/100ML
>A> @ HOSPIRA 7%;102MG/100ML;45MG/100ML;522MG/ N19437 006 Apr 03, 1986 Ma CAHN
100ML;410MG/100ML
AMINOSYN II 8.5% W/ ELECTROLYTES
>D> ABBOTT 8.5%;102MG/100ML;45MG/100ML;522M N19437 005 Apr 03, 1986 Ma CAHN
G/100ML;410MG/100ML
>A> HOSPIRA 8.5%;102MG/100ML;45MG/100ML;522M N19437 005 Apr 03, 1986 Ma CAHN
G/100ML;410MG/100ML
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM
INJECTABLE; INJECTION
AMINOSYN II 3.5% M
>D> @ ABBOTT 3.5%;30MG/100ML;97MG/100ML;120MG/ N19437 007 Apr 03, 1986 Ma CAHN
100ML;49MG/100ML
>A> @ HOSPIRA 3.5%;30MG/100ML;97MG/100ML;120MG/ N19437 007 Apr 03, 1986 Ma CAHN
100ML;49MG/100ML
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
INJECTABLE; INJECTION
AMINOSYN 7% W/ ELECTROLYTES
>D> ABBOTT 7%;102MG/100ML;522MG/100ML;410MG N17789 002 Ma CAHN
>A> HOSPIRA 7%;102MG/100ML;522MG/100ML;410MG N17789 002 Ma CAHN
AMINOSYN 8.5% W/ ELECTROLYTES
>D> ABBOTT 8.5%;102MG/100ML;522MG/100ML;410M N17673 005 Ma CAHN
G/100ML
>A> HOSPIRA 8.5%;102MG/100ML;522MG/100ML;410M N17673 005 Ma CAHN
G/100ML
AMINOCAPROIC ACID
INJECTABLE; INJECTION
AMINOCAPROIC ACID
>D> AP ABBOTT 250MG/ML N70888 001 Jun 16, 1988 Ma CAHN
>A> AP HOSPIRA 250MG/ML N70888 001 Jun 16, 1988 Ma CAHN
AMINOCAPROIC ACID IN PLASTIC CONTAINER
>D> AP ABBOTT 250MG/ML N70010 001 Mar 09, 1987 Ma CAHN
>A> AP HOSPIRA 250MG/ML N70010 001 Mar 09, 1987 Ma CAHN
AMINOPHYLLINE
INJECTABLE; INJECTION
AMINOPHYLLINE
>D> AP + ABBOTT 25MG/ML N87601 001 Jul 23, 1982 Ma CAHN
>D> AP 25MG/ML N87242 001 Oct 26, 1983 Ma CAHN
>A> AP + HOSPIRA 25MG/ML N87601 001 Jul 23, 1982 Ma CAHN
>A> AP 25MG/ML N87242 001 Oct 26, 1983 Ma CAHN
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%
>D> + ABBOTT 100MG/100ML N88147 002 May 03, 1983 Ma CAHN
>D> + 200MG/100ML N88147 003 May 03, 1983 Ma CAHN
>A> + HOSPIRA 100MG/100ML N88147 002 May 03, 1983 Ma CAHN
>A> + 200MG/100ML N88147 003 May 03, 1983 Ma CAHN
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
>D> @ ABBOTT 100MG/100ML N18924 001 Dec 12, 1984 Ma CAHN
>D> @ 200MG/100ML N18924 002 Dec 12, 1984 Ma CAHN
>D> @ ABBOTT 400MG/100ML N18924 003 Dec 12, 1984 Ma CAHN
>D> @ 500MG/100ML N18924 004 Dec 12, 1984 Ma CAHN
>A> @ HOSPIRA 100MG/100ML N18924 001 Dec 12, 1984 Ma CAHN
>A> @ 200MG/100ML N18924 002 Dec 12, 1984 Ma CAHN
>A> @ 400MG/100ML N18924 003 Dec 12, 1984 Ma CAHN
>A> @ 500MG/100ML N18924 004 Dec 12, 1984 Ma CAHN
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION
AMIODARONE HCL
>D> AP ABBOTT 50MG/ML N75955 001 Oct 18, 2002 Ma CAHN
>A> AP HOSPIRA 50MG/ML N75955 001 Oct 18, 2002 Ma CAHN
AMMONIUM CHLORIDE
INJECTABLE; INJECTION
AMMONIUM CHLORIDE IN PLASTIC CONTAINER
>D> + ABBOTT 5MEQ/ML N88366 001 Jun 13, 1984 Ma CAHN
>A> + HOSPIRA 5MEQ/ML N88366 001 Jun 13, 1984 Ma CAHN
AMMONIUM LACTATE
LOTION; TOPICAL
AMMONIUM LACTATE
>A> AB TARO EQ 12% BASE N76216 001 May 28, 2004 Ma NEWA
AMOXICILLIN; CLAVULANATE POTASSIUM
FOR SUSPENSION; ORAL
AMOXICILLIN AND CLAVULANATE POTASSIUM
>A> AB TEVA 200MG/5ML;EQ 28.5MG BASE/5ML N65089 001 May 25, 2004 Ma NEWA
>A> AB 400MG/5ML;EQ 57MG BASE/5ML N65089 002 May 25, 2004 Ma NEWA
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID;
INJECTABLE; INJECTION
M.V.I.-12
>A> + MAYNE PHARMA 20MG/ML;0.006MG/ML;0.5UGM/ML;1.5M N08809 005 Apr 22, 2004 Ma NEWA
G/ML;20
IU/ML;0.6MG/ML;4MG/ML;0.4MG/ML;0.36
MG/ML;0.6MG/ML;330 UNITS/ML;1 IU/ML
ATRACURIUM BESYLATE
INJECTABLE; INJECTION
ATRACURIUM BESYLATE
>D> AP ABBOTT 10MG/ML N74632 001 Dec 23, 1996 Ma CAHN
>A> AP HOSPIRA 10MG/ML N74632 001 Dec 23, 1996 Ma CAHN
ATRACURIUM BESYLATE PRESERVATIVE FREE
>D> AP ABBOTT 10MG/ML N74639 001 Mar 25, 1997 Ma CAHN
>D> AP 10MG/ML N74633 001 Dec 23, 1996 Ma CAHN
>A> AP HOSPIRA 10MG/ML N74639 001 Mar 25, 1997 Ma CAHN
>A> AP 10MG/ML N74633 001 Dec 23, 1996 Ma CAHN
TRACRIUM
>D> AP + ABBOTT 10MG/ML N18831 002 Jun 20, 1985 Ma CAHN
>A> AP + HOSPIRA 10MG/ML N18831 002 Jun 20, 1985 Ma CAHN
TRACRIUM PRESERVATIVE FREE
>D> AP + ABBOTT 10MG/ML N18831 001 Nov 23, 1983 Ma CAHN
>A> AP + HOSPIRA 10MG/ML N18831 001 Nov 23, 1983 Ma CAHN
ATROPINE SULFATE
INJECTABLE; IM-IV-SC
ATROPINE SULFATE ANSYR PLASTIC SYRINGE
>D> ABBOTT 0.05MG/ML N21146 002 Jul 09, 2001 Ma CAHN
>D> + 0.1MG/ML N21146 001 Jul 09, 2001 Ma CAHN
>A> HOSPIRA 0.05MG/ML N21146 002 Jul 09, 2001 Ma CAHN
>A> + 0.1MG/ML N21146 001 Jul 09, 2001 Ma CAHN
ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE
TABLET; ORAL
MOTOFEN
>D> + AMARIN PHARMS 0.025MG;1MG N17744 002 Ma CAHN
>A> + VALEANT 0.025MG;1MG N17744 002 Ma CAHN
MOTOFEN HALF-STRENGTH
>D> @ AMARIN PHARMS 0.025MG;0.5MG N17744 001 Ma CAHN
>A> @ VALEANT 0.025MG;0.5MG N17744 001 Ma CAHN
>A> AZACITIDINE
>A> INJECTABLE; SUBCUTANEOUS
>A> VIDAZA
>A> + PHARMION 100MG/VIAL N50794 001 May 19, 2004 Ma NEWA
>D> AZATADINE MALEATE
>D> TABLET; ORAL
>D> OPTIMINE
>D> + SCHERING 1MG N17601 001 Ma DISC
>A> @ 1MG N17601 001 Ma DISC
>D> AZATADINE MALEATE; PSEUDOEPHEDRINE SULFATE
>D> TABLET, EXTENDED RELEASE; ORAL
>D> TRINALIN
>D> + SCHERING 1MG;120MG N18506 001 Mar 23, 1982 Ma DISC
>A> @ 1MG;120MG N18506 001 Mar 23, 1982 Ma DISC
AZATHIOPRINE SODIUM
INJECTABLE; INJECTION
AZATHIOPRINE SODIUM
>D> AP BEDFORD EQ 100MG BASE/VIAL N74419 001 Mar 31, 1995 Ma CRLD
>A> + EQ 100MG BASE/VIAL N74419 001 Mar 31, 1995 Ma CRLD
>D> IMURAN
>D> AP + PROMETHEUS LABS EQ 100MG BASE/VIAL N17391 001 Ma DISC
>A> @ EQ 100MG BASE/VIAL N17391 001 Ma DISC
>A> BISACODYL; POLYETHYLENE GLYCOL; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM
>A> FOR SOLUTION; TABLET, DELAYED RELEASE; ORAL
>A> HALFLYTELY
>A> + BRAINTREE 5MG;210GM;0.74GM;2.86GM;5.6GM N21551 001 May 10, 2004 Ma NEWA
BRETYLIUM TOSYLATE
INJECTABLE; INJECTION
BRETYLIUM TOSYLATE
>D> AP + ABBOTT 50MG/ML N19033 001 Apr 29, 1986 Ma CAHN
>A> AP + HOSPIRA 50MG/ML N19033 001 Apr 29, 1986 Ma CAHN
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP + ABBOTT 200MG/100ML N19008 002 Apr 29, 1986 Ma CAHN
>D> AP + 400MG/100ML N19008 003 Apr 29, 1986 Ma CAHN
>D> @ 800MG/100ML N19008 001 Apr 29, 1986 Ma CAHN
>A> AP + HOSPIRA 200MG/100ML N19008 002 Apr 29, 1986 Ma CAHN
>A> AP + 400MG/100ML N19008 003 Apr 29, 1986 Ma CAHN
>A> @ 800MG/100ML N19008 001 Apr 29, 1986 Ma CAHN
BRETYLIUM TOSYLATE IN PLASTIC CONTAINER
>D> AP + ABBOTT 50MG/ML N19030 001 Apr 29, 1986 Ma CAHN
>A> AP + HOSPIRA 50MG/ML N19030 001 Apr 29, 1986 Ma CAHN
BUMETANIDE
INJECTABLE; INJECTION
BUMETANIDE
>D> AP ABBOTT 0.25MG/ML N74332 001 Oct 31, 1994 Ma CAHN
>D> AP 0.25MG/ML N74160 001 Oct 30, 1997 Ma CAHN
>A> AP HOSPIRA 0.25MG/ML N74332 001 Oct 31, 1994 Ma CAHN
>A> AP 0.25MG/ML N74160 001 Oct 30, 1997 Ma CAHN
BUPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
BUPIVACAINE HCL
>D> AP ABBOTT 0.25% N70590 001 Feb 17, 1987 Ma CAHN
>D> AP 0.25% N70586 001 Mar 03, 1987 Ma CAHN
>D> AP 0.25% N70583 001 Feb 17, 1987 Ma CAHN
>D> AP 0.25% N18053 002 Ma CAHN
>D> AP 0.5% N70609 001 Mar 03, 1987 Ma CAHN
>D> AP 0.5% N70597 001 Mar 03, 1987 Ma CAHN
>D> AP 0.5% N70584 001 Feb 17, 1986 Ma CAHN
>D> AP 0.5% N18053 001 Ma CAHN
>D> AP 0.75% N70587 001 Mar 03, 1987 Ma CAHN
>D> AP 0.75% N70585 001 Mar 03, 1987 Ma CAHN
>D> AP 0.75% N18053 003 Ma CAHN
>A> AP HOSPIRA 0.25% N70590 001 Feb 17, 1987 Ma CAHN
>A> AP 0.25% N70586 001 Mar 03, 1987 Ma CAHN
>A> AP 0.25% N70583 001 Feb 17, 1987 Ma CAHN
>A> AP 0.25% N18053 002 Ma CAHN
>A> AP 0.5% N70609 001 Mar 03, 1987 Ma CAHN
>A> AP 0.5% N70597 001 Mar 03, 1987 Ma CAHN
>A> AP 0.5% N70584 001 Feb 17, 1986 Ma CAHN
>A> AP 0.5% N18053 001 Ma CAHN
>A> AP 0.75% N70587 001 Mar 03, 1987 Ma CAHN
>A> AP 0.75% N70585 001 Mar 03, 1987 Ma CAHN
>A> AP 0.75% N18053 003 Ma CAHN
BUPIVACAINE HCL KIT
>D> @ ABBOTT 0.075% N19978 001 Sep 03, 1992 Ma CAHN
>D> @ 0.114% N19978 002 Sep 03, 1992 Ma CAHN
>D> @ 0.23% N19978 003 Sep 03, 1992 Ma CAHN
>A> @ HOSPIRA 0.075% N19978 001 Sep 03, 1992 Ma CAHN
>A> @ 0.114% N19978 002 Sep 03, 1992 Ma CAHN
>A> @ 0.23% N19978 003 Sep 03, 1992 Ma CAHN
MARCAINE HCL
>D> AP + ABBOTT 0.25% N16964 001 Ma CAHN
>D> AP + 0.5% N16964 006 Ma CAHN
>A> AP + HOSPIRA 0.25% N16964 001 Ma CAHN
>A> AP + 0.5% N16964 006 Ma CAHN
MARCAINE HCL PRESERVATIVE FREE
>D> AP + ABBOTT 0.25% N16964 012 Ma CAHN
>D> AP + 0.5% N16964 005 Ma CAHN
>D> AP + 0.75% N16964 009 Ma CAHN
>A> AP + HOSPIRA 0.25% N16964 012 Ma CAHN
>A> AP + 0.5% N16964 005 Ma CAHN
>A> AP + 0.75% N16964 009 Ma CAHN
INJECTABLE; SPINAL
BUPIVACAINE
>D> AP ABBOTT 0.75% N71810 001 Dec 11, 1987 Ma CAHN
>A> AP HOSPIRA 0.75% N71810 001 Dec 11, 1987 Ma CAHN
MARCAINE
>D> AP + ABBOTT 0.75% N18692 001 May 04, 1984 Ma CAHN
>A> AP + HOSPIRA 0.75% N18692 001 May 04, 1984 Ma CAHN
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
INJECTABLE; INJECTION
BUPIVACAINE HCL AND EPINEPHRINE
>D> ABBOTT 0.25%;0.005MG/ML N71167 001 Jun 16, 1988 Ma CAHN
>D> 0.25%;0.005MG/ML N71166 001 Jun 16, 1988 Ma CAHN
>D> + 0.25%;0.005MG/ML N71165 001 Jun 16, 1988 Ma CAHN
>D> 0.5%;0.005MG/ML N71170 001 Jun 16, 1988 Ma CAHN
>D> 0.5%;0.005MG/ML N71169 001 Jun 16, 1988 Ma CAHN
>D> + 0.5%;0.005MG/ML N71168 001 Jun 16, 1988 Ma CAHN
>D> + 0.75%;0.005MG/ML N71171 001 Jun 16, 1988 Ma CAHN
>A> HOSPIRA 0.25%;0.005MG/ML N71167 001 Jun 16, 1988 Ma CAHN
>A> 0.25%;0.005MG/ML N71166 001 Jun 16, 1988 Ma CAHN
>A> + 0.25%;0.005MG/ML N71165 001 Jun 16, 1988 Ma CAHN
>A> 0.5%;0.005MG/ML N71170 001 Jun 16, 1988 Ma CAHN
>A> 0.5%;0.005MG/ML N71169 001 Jun 16, 1988 Ma CAHN
>A> + 0.5%;0.005MG/ML N71168 001 Jun 16, 1988 Ma CAHN
>A> + 0.75%;0.005MG/ML N71171 001 Jun 16, 1988 Ma CAHN
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE; INJECTION
MARCAINE HCL W/ EPINEPHRINE
>D> AP + ABBOTT 0.25%;0.0091MG/ML N16964 004 Ma CAHN
>D> AP + 0.5%;0.0091MG/ML N16964 008 Ma CAHN
>A> AP + HOSPIRA 0.25%;0.0091MG/ML N16964 004 Ma CAHN
>A> AP + 0.5%;0.0091MG/ML N16964 008 Ma CAHN
MARCAINE HCL W/ EPINEPHRINE PRESERVATIVE FREE
>D> AP + ABBOTT 0.25%;0.0091MG/ML N16964 013 Ma CAHN
>D> AP + 0.5%;0.0091MG/ML N16964 007 Ma CAHN
>D> AP + 0.75%;0.0091MG/ML N16964 010 Ma CAHN
>A> AP + HOSPIRA 0.25%;0.0091MG/ML N16964 013 Ma CAHN
>A> AP + 0.5%;0.0091MG/ML N16964 007 Ma CAHN
>A> AP + HOSPIRA 0.75%;0.0091MG/ML N16964 010 Ma CAHN
BUPRENORPHINE HYDROCHLORIDE
INJECTABLE; INJECTION
BUPRENORPHINE HCL
>D> AP ABBOTT EQ 0.3MG BASE/ML N74137 001 Jun 03, 1996 Ma CAHN
>A> AP HOSPIRA EQ 0.3MG BASE/ML N74137 001 Jun 03, 1996 Ma CAHN
BUPROPION HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
BUPROPION HCL
>D> AB EON 100MG N75932 001 Nov 25, 2003 Ma CFTG
>A> AB1 100MG N75932 001 Nov 25, 2003 Ma CFTG
>D> AB 150MG N75932 002 Mar 22, 2004 Ma CTEC
>A> AB1 150MG N75932 002 Mar 22, 2004 Ma CTEC
>D> AB IMPAX LABS 100MG N75913 001 Jan 28, 2004 Ma CTEC
>A> AB1 100MG N75913 001 Jan 28, 2004 Ma CTEC
>A> AB2 150MG N75914 001 May 27, 2004 Ma NEWA
>D> AB 150MG N75913 002 Mar 22, 2004 Ma CTEC
>A> AB1 150MG N75913 002 Mar 22, 2004 Ma CTEC
WELLBUTRIN SR
>D> AB GLAXOSMITHKLINE 100MG N20358 002 Oct 04, 1996 Ma CTEC
>A> AB 100MG N20358 002 Oct 04, 1996 Ma CTEC
>D> AB + 150MG N20358 003 Oct 04, 1996 Ma CTEC
>A> AB + 150MG N20358 003 Oct 04, 1996 Ma CTEC
ZYBAN
>D> + GLAXOSMITHKLINE 150MG N20711 003 May 14, 1997 Ma CFTG
>A> AB + 150MG N20711 003 May 14, 1997 Ma CFTG
BUTORPHANOL TARTRATE
INJECTABLE; INJECTION
BUTORPHANOL TARTRATE
>D> AP ABBOTT 1MG/ML N75559 001 Mar 20, 2000 Ma CAHN
>D> AP 2MG/ML N75559 002 Mar 20, 2000 Ma CAHN
>A> AP HOSPIRA 1MG/ML N75559 001 Mar 20, 2000 Ma CAHN
>A> AP 2MG/ML N75559 002 Mar 20, 2000 Ma CAHN
BUTORPHANOL TARTRATE PRESERVATIVE FREE
>D> AP ABBOTT 1MG/ML N74626 001 Jan 23, 1997 Ma CAHN
>D> AP 1MG/ML N74620 001 Jan 22, 1997 Ma CAHN
>D> AP 2MG/ML N74626 002 Jan 23, 1997 Ma CAHN
>D> AP 2MG/ML N74620 002 Jan 22, 1997 Ma CAHN
>A> AP HOSPIRA 1MG/ML N74626 001 Jan 23, 1997 Ma CAHN
>A> AP 1MG/ML N74620 001 Jan 22, 1997 Ma CAHN
>A> AP 2MG/ML N74626 002 Jan 23, 1997 Ma CAHN
>A> AP 2MG/ML N74620 002 Jan 22, 1997 Ma CAHN
CALCIUM CHLORIDE
INJECTABLE; INJECTION
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER
>D> + ABBOTT 100MG/ML N21117 001 Jan 28, 2000 Ma CAHN
>A> + HOSPIRA 100MG/ML N21117 001 Jan 28, 2000 Ma CAHN
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE; INJECTION
DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER
>D> AP ABBOTT 33MG/100ML;5GM/100ML;30MG/100ML;8 N18254 001 Ma CAHN
60MG/100ML
>A> AP HOSPIRA 33MG/100ML;5GM/100ML;30MG/100ML;8 N18254 001 Ma CAHN
60MG/100ML
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE; INJECTION
DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
>D> AP ABBOTT 20MG/100ML;5GM/100ML;30MG/100ML;6 N17608 001 Ma CAHN
00MG/100ML;310MG/100ML
>A> AP HOSPIRA 20MG/100ML;5GM/100ML;30MG/100ML;6 N17608 001 Ma CAHN
00MG/100ML;310MG/100ML
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC
>D> @ ABBOTT 20MG/100ML;5GM/100ML;104MG/100ML; N19685 005 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>D> @ ABBOTT 20MG/100ML;5GM/100ML;179MG/100ML; N19685 006 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> @ HOSPIRA 20MG/100ML;5GM/100ML;104MG/100ML; N19685 005 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> @ 20MG/100ML;5GM/100ML;179MG/100ML; N19685 006 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC
>D> @ ABBOTT 20MG/100ML;5GM/100ML;254MG/100ML; N19685 007 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> @ HOSPIRA 20MG/100ML;5GM/100ML;254MG/100ML; N19685 007 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC
>D> AP ABBOTT 20MG/100ML;5GM/100ML;179MG/100ML; N19685 002 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>D> AP 20MG/100ML;5GM/100ML;328MG/100ML; N19685 008 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> AP HOSPIRA 20MG/100ML;5GM/100ML;179MG/100ML; N19685 002 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> AP 20MG/100ML;5GM/100ML;328MG/100ML; N19685 008 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC
>D> @ ABBOTT 20MG/100ML;5GM/100ML;254MG/100ML; N19685 003 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> @ HOSPIRA 20MG/100ML;5GM/100ML;254MG/100ML; N19685 003 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC
>D> AP ABBOTT 20MG/100ML;5GM/100ML;328MG/100ML; N19685 004 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> AP HOSPIRA 20MG/100ML;5GM/100ML;328MG/100ML; N19685 004 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
>D> @ ABBOTT 20MG/100ML;5GM/100ML;104MG/100ML; N19685 001 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
>A> @ HOSPIRA 20MG/100ML;5GM/100ML;104MG/100ML; N19685 001 Oct 17, 1988 Ma CAHN
600MG/100ML;310MG/100ML
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM
INJECTABLE; INJECTION
TPN ELECTROLYTES IN PLASTIC CONTAINER
>D> ABBOTT 16.5MG/ML;25.4MG/ML;74.6MG/ML;121M N18895 001 Jul 20, 1984 Ma CAHN
G/ML;16.1MG/ML
>A> HOSPIRA 16.5MG/ML;25.4MG/ML;74.6MG/ML;121M N18895 001 Jul 20, 1984 Ma CAHN
G/ML;16.1MG/ML
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
SOLUTION; PERFUSION, CARDIAC
PLEGISOL IN PLASTIC CONTAINER
>D> AT + ABBOTT 17.6MG/100ML;325.3MG/100ML;119.3MG N18608 001 Feb 26, 1982 Ma CAHN
/100ML;643MG/100ML
>A> AT + HOSPIRA 17.6MG/100ML;325.3MG/100ML;119.3MG N18608 001 Feb 26, 1982 Ma CAHN
/100ML;643MG/100ML
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE; INJECTION
RINGER'S IN PLASTIC CONTAINER
>D> AP ABBOTT 33MG/100ML;30MG/100ML;860MG/100M N18251 001 Ma CAHN
>A> AP HOSPIRA 33MG/100ML;30MG/100ML;860MG/100M N18251 001 Ma CAHN
SOLUTION; IRRIGATION
RINGER'S IN PLASTIC CONTAINER
>D> AT ABBOTT 33MG/100ML;30MG/100ML;860MG/100M N17635 001 Ma CAHN
>A> AT HOSPIRA 33MG/100ML;30MG/100ML;860MG/100M N17635 001 Ma CAHN
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
INJECTABLE; INJECTION
LACTATED RINGER'S IN PLASTIC CONTAINER
>D> AP ABBOTT 20MG/100ML;30MG/100ML;600MG/100M N17641 001 Ma CAHN
L;310MG/100ML
>A> AP HOSPIRA 20MG/100ML;30MG/100ML;600MG/100M N17641 001 Ma CAHN
L;310MG/100ML
SOLUTION; IRRIGATION
LACTATED RINGER'S IN PLASTIC CONTAINER
>D> AT ABBOTT 20MG/100ML;30MG/100ML;600MG/100M N19416 001 Jan 17, 1986 Ma CAHN
L;310MG/100ML
>A> AT HOSPIRA 20MG/100ML;30MG/100ML;600MG/100M N19416 001 Jan 17, 1986 Ma CAHN
L;310MG/100ML
CAPTOPRIL
TABLET; ORAL
CAPTOPRIL
>A> AB DURAMED PHARMS 12.5MG N74477 001 Feb 13, 1996 Ma CAHN
>A> AB 25MG N74477 002 Feb 13, 1996 Ma CAHN
>A> AB 50MG N74477 003 Feb 13, 1996 Ma CAHN
>A> AB 100MG N74477 004 Feb 13, 1996 Ma CAHN
>D> AB HALLMARK PHARMS 12.5MG N74477 001 Feb 13, 1996 Ma CAHN
>D> AB 25MG N74477 002 Feb 13, 1996 Ma CAHN
>D> AB 50MG N74477 003 Feb 13, 1996 Ma CAHN
>D> AB 100MG N74477 004 Feb 13, 1996 Ma CAHN
CARBIDOPA; LEVODOPA
TABLET, EXTENDED RELEASE; ORAL
CARBIDOPA AND LEVODOPA
>A> AB IMPAX LABS 25MG;100MG N76521 001 May 14, 2004 Ma NEWA
>A> AB 50MG;200MG N76521 002 May 14, 2004 Ma NEWA
CEFACLOR
FOR SUSPENSION; ORAL
CECLOR
>A> AB CEPH INTL EQ 125MG BASE/5ML N62206 001 Ma CAHN
>A> AB EQ 187MG BASE/5ML N62206 003 Apr 20, 1988 Ma CAHN
>A> AB EQ 250MG BASE/5ML N62206 002 Ma CAHN
>A> AB + EQ 375MG BASE/5ML N62206 004 Apr 20, 1988 Ma CAHN
>D> AB LILLY EQ 125MG BASE/5ML N62206 001 Ma CAHN
>D> AB EQ 187MG BASE/5ML N62206 003 Apr 20, 1988 Ma CAHN
>D> AB EQ 250MG BASE/5ML N62206 002 Ma CAHN
>D> AB + EQ 375MG BASE/5ML N62206 004 Apr 20, 1988 Ma CAHN
CEFTAZIDIME
INJECTABLE; INJECTION
TAZICEF
>D> AP ABBOTT 500MG/VIAL N62662 001 Mar 06, 1986 Ma CAHN
>D> AP 1GM/VIAL N64032 001 Oct 31, 1993 Ma CAHN
>D> AP 1GM/VIAL N62662 002 Mar 06, 1986 Ma CAHN
>D> AP 2GM/VIAL N64032 002 Oct 31, 1993 Ma CAHN
>D> AP 2GM/VIAL N62662 003 Mar 06, 1986 Ma CAHN
>D> AP 6GM/VIAL N62662 004 Mar 06, 1986 Ma CAHN
>A> AP HOSPIRA 500MG/VIAL N62662 001 Mar 06, 1986 Ma CAHN
>A> AP 1GM/VIAL N64032 001 Oct 31, 1993 Ma CAHN
>A> AP 1GM/VIAL N62662 002 Mar 06, 1986 Ma CAHN
>A> AP 2GM/VIAL N64032 002 Oct 31, 1993 Ma CAHN
>A> AP 2GM/VIAL N62662 003 Mar 06, 1986 Ma CAHN
>A> AP 6GM/VIAL N62662 004 Mar 06, 1986 Ma CAHN
CHLOROPROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
CHLOROPROCAINE HCL
>D> AP ABBOTT 2% N87447 001 Apr 16, 1982 Ma CAHN
>D> AP 3% N87446 001 Apr 16, 1982 Ma CAHN
>A> AP HOSPIRA 2% N87447 001 Apr 16, 1982 Ma CAHN
>A> AP 3% N87446 001 Apr 16, 1982 Ma CAHN
CHORIOGONADOTROPIN ALFA
>D> INJECTABLE; INJECTION
>D> OVIDREL
>D> + SERONO INC 0.25MG/VIAL N21149 001 Sep 20, 2000 Ma DISC
>A> @ 0.25MG/VIAL N21149 001 Sep 20, 2000 Ma DISC
CHROMIC CHLORIDE
INJECTABLE; INJECTION
CHROMIC CHLORIDE IN PLASTIC CONTAINER
>D> + ABBOTT EQ 0.004MG CHROMIUM/ML N18961 001 Jun 26, 1986 Ma CAHN
>A> + HOSPIRA EQ 0.004MG CHROMIUM/ML N18961 001 Jun 26, 1986 Ma CAHN
CIMETIDINE HYDROCHLORIDE
INJECTABLE; INJECTION
CIMETIDINE HCL
>D> AP ABBOTT EQ 300MG BASE/2ML N74422 001 Jan 31, 1995 Ma CAHN
>D> AP EQ 300MG BASE/2ML N74412 001 Mar 28, 1997 Ma CAHN
>D> AP EQ 300MG BASE/2ML N74345 001 Jan 31, 1995 Ma CAHN
>D> AP EQ 300MG BASE/2ML N74344 001 Jan 31, 1995 Ma CAHN
>D> AP EQ 300MG BASE/2ML N74296 001 Mar 28, 1997 Ma CAHN
>A> AP HOSPIRA EQ 300MG BASE/2ML N74422 001 Jan 31, 1995 Ma CAHN
>A> AP EQ 300MG BASE/2ML N74412 001 Mar 28, 1997 Ma CAHN
>A> AP EQ 300MG BASE/2ML N74345 001 Jan 31, 1995 Ma CAHN
>A> AP EQ 300MG BASE/2ML N74344 001 Jan 31, 1995 Ma CAHN
>A> AP EQ 300MG BASE/2ML N74296 001 Mar 28, 1997 Ma CAHN
CIMETIDINE HCL IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> AP ABBOTT EQ 6MG BASE/ML N74269 001 Dec 27, 1994 Ma CAHN
>D> + EQ 90MG BASE/100ML N74468 005 Dec 29, 1994 Ma CAHN
>D> + EQ 120MG BASE/100ML N74468 006 Dec 29, 1994 Ma CAHN
>D> + EQ 180MG BASE/100ML N74468 003 Dec 29, 1994 Ma CAHN
>D> + EQ 240MG BASE/100ML N74468 004 Dec 29, 1994 Ma CAHN
>D> + EQ 360MG BASE/100ML N74468 001 Dec 29, 1994 Ma CAHN
>D> + EQ 480MG BASE/100ML N74468 002 Dec 29, 1994 Ma CAHN
>A> AP HOSPIRA EQ 6MG BASE/ML N74269 001 Dec 27, 1994 Ma CAHN
>A> + EQ 90MG BASE/100ML N74468 005 Dec 29, 1994 Ma CAHN
>A> + EQ 120MG BASE/100ML N74468 006 Dec 29, 1994 Ma CAHN
>A> + EQ 180MG BASE/100ML N74468 003 Dec 29, 1994 Ma CAHN
>A> + EQ 240MG BASE/100ML N74468 004 Dec 29, 1994 Ma CAHN
>A> + EQ 360MG BASE/100ML N74468 001 Dec 29, 1994 Ma CAHN
>A> + EQ 480MG BASE/100ML N74468 002 Dec 29, 1994 Ma CAHN
CITRIC ACID; MAGNESIUM OXIDE; SODIUM CARBONATE
SOLUTION; IRRIGATION
UROLOGIC G IN PLASTIC CONTAINER
>D> AT ABBOTT 3.24GM/100ML;380MG/100ML;430MG/10 N18904 001 May 27, 1983 Ma CAHN
>A> AT HOSPIRA 3.24GM/100ML;380MG/100ML;430MG/10 N18904 001 May 27, 1983 Ma CAHN
CLARITHROMYCIN
TABLET; ORAL
BIAXIN
>D> + ABBOTT 250MG N50662 001 Oct 31, 1991 Ma CFTG
>A> AB + 250MG N50662 001 Oct 31, 1991 Ma CFTG
>D> + 500MG N50662 002 Oct 31, 1991 Ma CFTG
>A> AB + 500MG N50662 002 Oct 31, 1991 Ma CFTG
>A> CLARITHROMYCIN
>A> AB ROXANE 250MG N65178 002 May 25, 2004 Ma NEWA
>A> AB 500MG N65178 001 May 25, 2004 Ma NEWA
CLINDAMYCIN PALMITATE HYDROCHLORIDE
FOR SOLUTION; ORAL
CLEOCIN
>D> PHARMACIA AND EQ 75MG BASE/5ML N62644 001 Apr 07, 1986 Ma CRLD
>A> + EQ 75MG BASE/5ML N62644 001 Apr 07, 1986 Ma CRLD
CLINDAMYCIN PHOSPHATE
INJECTABLE; INJECTION
CLINDAMYCIN PHOSPHATE
>D> @ ABBOTT EQ 150MG BASE/ML N62943 001 Sep 29, 1988 Ma CAHN
>D> AP EQ 150MG BASE/ML N62801 001 Jul 24, 1987 Ma CAHN
>D> AP EQ 150MG BASE/ML N62800 001 Jul 24, 1987 Ma CAHN
>A> @ HOSPIRA EQ 150MG BASE/ML N62943 001 Sep 29, 1988 Ma CAHN
>A> AP EQ 150MG BASE/ML N62801 001 Jul 24, 1987 Ma CAHN
>A> AP EQ 150MG BASE/ML N62800 001 Jul 24, 1987 Ma CAHN
CUPRIC CHLORIDE
INJECTABLE; INJECTION
CUPRIC CHLORIDE IN PLASTIC CONTAINER
>D> + ABBOTT EQ 0.4MG COPPER/ML N18960 001 Jun 26, 1986 Ma CAHN
>A> + HOSPIRA EQ 0.4MG COPPER/ML N18960 001 Jun 26, 1986 Ma CAHN
DEFEROXAMINE MESYLATE
INJECTABLE; INJECTION
DEFEROXAMINE MESYLATE
>D> AP ABBOTT 500MG/VIAL N76019 001 Mar 17, 2004 Ma CAHN
>D> AP 2GM/VIAL N76019 002 Mar 17, 2004 Ma CAHN
>A> AP HOSPIRA 500MG/VIAL N76019 001 Mar 17, 2004 Ma CAHN
>A> AP 2GM/VIAL N76019 002 Mar 17, 2004 Ma CAHN
DESMOPRESSIN ACETATE
INJECTABLE; INJECTION
DESMOPRESSIN ACETATE
>D> AP ABBOTT 0.004MG/ML N75220 001 Aug 28, 2000 Ma CAHN
>A> AP HOSPIRA 0.004MG/ML N75220 001 Aug 28, 2000 Ma CAHN
DEXMEDETOMIDINE
INJECTABLE; INJECTION
PRECEDEX
>D> + ABBOTT EQ 100UGM BASE/ML N21038 001 Dec 17, 1999 Ma CAHN
>A> + HOSPIRA EQ 100UGM BASE/ML N21038 001 Dec 17, 1999 Ma CAHN
DEXTROSE
INJECTABLE; INJECTION
DEXTROSE 10% IN PLASTIC CONTAINER
>D> AP ABBOTT 10GM/100ML N18080 001 Ma CAHN
>A> AP HOSPIRA 10GM/100ML N18080 001 Ma CAHN
DEXTROSE 2.5% IN PLASTIC CONTAINER
>D> B BRAUN 2.5GM/100ML N18358 001 Ma DISC
>A> @ 2.5GM/100ML N18358 001 Ma DISC
DEXTROSE 20% IN PLASTIC CONTAINER
>D> AP ABBOTT 20GM/100ML N18564 001 Mar 23, 1982 Ma CAHN
>A> AP HOSPIRA 20GM/100ML N18564 001 Mar 23, 1982 Ma CAHN
DEXTROSE 25%
>D> ABBOTT 250MG/ML N19445 002 Nov 23, 1998 Ma CAHN
>A> HOSPIRA 250MG/ML N19445 002 Nov 23, 1998 Ma CAHN
DEXTROSE 30% IN PLASTIC CONTAINER
>D> AP ABBOTT 30GM/100ML N19345 001 Jan 26, 1985 Ma CAHN
>A> AP HOSPIRA 30GM/100ML N19345 001 Jan 26, 1985 Ma CAHN
DEXTROSE 40% IN PLASTIC CONTAINER
>D> AP ABBOTT 40GM/100ML N18562 001 Mar 23, 1982 Ma CAHN
>A> AP HOSPIRA 40GM/100ML N18562 001 Mar 23, 1982 Ma CAHN
DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP ABBOTT 50MG/ML N19222 001 Jul 13, 1984 Ma CAHN
>D> AP 50MG/ML N16367 002 Ma CAHN
>D> AP 5GM/100ML N19479 001 Sep 17, 1985 Ma CAHN
>D> AP 5GM/100ML N19466 001 Jul 15, 1985 Ma CAHN
>A> AP HOSPIRA 50MG/ML N19222 001 Jul 13, 1984 Ma CAHN
>A> AP 50MG/ML N16367 002 Ma CAHN
>A> AP 5GM/100ML N19479 001 Sep 17, 1985 Ma CAHN
>A> AP 5GM/100ML N19466 001 Jul 15, 1985 Ma CAHN
DEXTROSE 50% IN PLASTIC CONTAINER
>D> @ ABBOTT 500MG/ML N19445 001 Jun 03, 1986 Ma CAHN
>D> AP 50GM/100ML N19894 001 Dec 26, 1989 Ma CAHN
>D> AP 50GM/100ML N18563 001 Mar 23, 1982 Ma CAHN
>A> @ HOSPIRA 500MG/ML N19445 001 Jun 03, 1986 Ma CAHN
>A> AP 50GM/100ML N19894 001 Dec 26, 1989 Ma CAHN
>A> AP 50GM/100ML N18563 001 Mar 23, 1982 Ma CAHN
DEXTROSE 60% IN PLASTIC CONTAINER
>D> AP ABBOTT 60GM/100ML N19346 001 Jan 25, 1985 Ma CAHN
>A> AP HOSPIRA 60GM/100ML N19346 001 Jan 25, 1985 Ma CAHN
DEXTROSE 70% IN PLASTIC CONTAINER
>D> AP ABBOTT 70GM/100ML N19893 001 Dec 26, 1989 Ma CAHN
>D> AP 70GM/100ML N18561 001 Mar 23, 1982 Ma CAHN
>A> AP HOSPIRA 70GM/100ML N19893 001 Dec 26, 1989 Ma CAHN
>A> AP 70GM/100ML N18561 001 Mar 23, 1982 Ma CAHN
DEXTROSE; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;21MG/100ML;128MG/100ML; N17610 001 Ma CAHN
234MG/100ML
>A> HOSPIRA 5GM/100ML;21MG/100ML;128MG/100ML; N17610 001 Ma CAHN
234MG/100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC;
INJECTABLE; INJECTION
>D> ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER
>D> B BRAUN 5GM/100ML;31MG/100ML;130MG/100ML; N19025 001 Dec 27, 1984 Ma DISC
26MG/100ML;320MG/100ML
>A> @ 5GM/100ML;31MG/100ML;130MG/100ML; N19025 001 Dec 27, 1984 Ma DISC
26MG/100ML;320MG/100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC;
INJECTABLE; INJECTION
IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;53MG/100ML;100MG/100ML; N19515 001 May 08, 1986 Ma CAHN
100MG/100ML;180MG/100ML;280MG/100
ML;16MG/100ML
>A> HOSPIRA 5GM/100ML;53MG/100ML;100MG/100ML; N19515 001 May 08, 1986 Ma CAHN
100MG/100ML;180MG/100ML;280MG/100
ML;16MG/100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC;
INJECTABLE; INJECTION
IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;30MG/100ML;141MG/100ML; N19513 001 May 08, 1986 Ma CAHN
15MG/100ML;260MG/100ML;25MG/100M
>A> HOSPIRA 5GM/100ML;30MG/100ML;141MG/100ML; N19513 001 May 08, 1986 Ma CAHN
15MG/100ML;260MG/100ML;25MG/100M
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
INJECTABLE; INJECTION
ISOLYTE H W/ DEXTROSE 5% IN PLASTIC CONTAINER
>D> B BRAUN 5GM/100ML;30MG/100ML;97MG/100ML;2 N18273 001 Ma DISC
20MG/100ML;140MG/100ML
>A> @ 5GM/100ML;30MG/100ML;97MG/100ML;2 N18273 001 Ma DISC
20MG/100ML;140MG/100ML
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE;
INJECTABLE; INJECTION
NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;30MG/100ML;37MG/100ML;2 N17609 001 Ma CAHN
22MG/100ML;526MG/100ML;502MG/100
>A> HOSPIRA 5GM/100ML;30MG/100ML;37MG/100ML;2 N17609 001 Ma CAHN
22MG/100ML;526MG/100ML;502MG/100
DEXTROSE; POTASSIUM CHLORIDE
INJECTABLE; INJECTION
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;149MG/100ML N18371 001 Ma CAHN
>A> HOSPIRA 5GM/100ML;149MG/100ML N18371 001 Ma CAHN
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP ABBOTT 5GM/100ML;224MG/100ML N18371 003 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;224MG/100ML N18371 003 Ma CAHN
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;298MG/100ML N18371 002 Ma CAHN
>A> HOSPIRA 5GM/100ML;298MG/100ML N18371 002 Ma CAHN
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM LACTATE; SODIUM CHLORIDE; SODIUM
INJECTABLE; INJECTION
IONOSOL T AND DEXTROSE 5% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;111MG/100ML;256MG/100M N19514 001 May 08, 1986 Ma CAHN
L;146MG/100ML;207MG/100ML
>A> HOSPIRA 5GM/100ML;111MG/100ML;256MG/100M N19514 001 May 08, 1986 Ma CAHN
L;146MG/100ML;207MG/100ML
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM
INJECTABLE; INJECTION
ISOLYTE M W/ DEXTROSE 5% IN PLASTIC CONTAINER
>D> B BRAUN 5GM/100ML;150MG/100ML;130MG/100M N18270 001 Ma DISC
L;280MG/100ML;91MG/100ML
>A> @ 5GM/100ML;150MG/100ML;130MG/100M N18270 001 Ma DISC
L;280MG/100ML;91MG/100ML
DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE; INJECTION
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC
>D> ABBOTT 5GM/100ML;74.5MG/100ML;225MG/100ML N18365 002 Jul 05, 1983 Ma CAHN
>D> 5GM/100ML;149MG/100ML;225MG/100M N18365 006 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;74.5MG/100ML;225MG/100ML N18365 002 Jul 05, 1983 Ma CAHN
>A> 5GM/100ML;149MG/100ML;225MG/100M N18365 006 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;74.5MG/100ML;300MG/100ML N18876 001 Jan 17, 1986 Ma CAHN
>D> 5GM/100ML;149MG/100ML;300MG/100M N18876 006 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;74.5MG/100ML;300MG/100ML N18876 001 Jan 17, 1986 Ma CAHN
>A> 5GM/100ML;149MG/100ML;300MG/100M N18876 006 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;74.5MG/100ML;450MG/100ML N18362 005 Mar 28, 1988 Ma CAHN
>D> AP 5GM/100ML;74.5MG/100ML;450MG/100ML N18362 009 Jul 05, 1983 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;74.5MG/100ML;450MG/100ML N18362 005 Mar 28, 1988 Ma CAHN
>A> AP 5GM/100ML;74.5MG/100ML;450MG/100ML N18362 009 Jul 05, 1983 Ma CAHN
POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;74.5MG/100ML;900MG/100ML N19691 002 Mar 24, 1988 Ma CAHN
>D> AP 5GM/100ML;149MG/100ML;900MG/100M N19691 004 Mar 24, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;74.5MG/100ML;900MG/100ML N19691 002 Mar 24, 1988 Ma CAHN
>A> AP 5GM/100ML;149MG/100ML;900MG/100M N19691 004 Mar 24, 1988 Ma CAHN
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC
>D> ABBOTT 5GM/100ML;224MG/100ML;225MG/100M N18365 008 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;224MG/100ML;225MG/100M N18365 008 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;224MG/100ML;300MG/100M N18876 007 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;224MG/100ML;300MG/100M N18876 007 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;224MG/100ML;450MG/100M N18362 006 Mar 28, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;224MG/100ML;450MG/100M N18362 006 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 15MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;224MG/100ML;900MG/100M N19691 006 Mar 24, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;224MG/100ML;900MG/100M N19691 006 Mar 24, 1988 Ma CAHN
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC
>D> ABBOTT 5GM/100ML;149MG/100ML;225MG/100M N18365 001 Ma CAHN
>D> 5GM/100ML;298MG/100ML;225MG/100M N18365 009 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;149MG/100ML;225MG/100M N18365 001 Ma CAHN
>A> 5GM/100ML;298MG/100ML;225MG/100M N18365 009 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;298MG/100ML;300MG/100M N18876 008 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;298MG/100ML;300MG/100M N18876 008 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;149MG/100ML;450MG/100M N18362 010 Jul 05, 1983 Ma CAHN
>D> AP 5GM/100ML;298MG/100ML;450MG/100M N18362 007 Mar 28, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;149MG/100ML;450MG/100M N18362 010 Jul 05, 1983 Ma CAHN
>A> AP 5GM/100ML;298MG/100ML;450MG/100M N18362 007 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;149MG/100ML;900MG/100M N19691 005 Mar 24, 1988 Ma CAHN
>D> AP 5GM/100ML;298MG/100ML;900MG/100M N19691 008 Mar 24, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;149MG/100ML;900MG/100M N19691 005 Mar 24, 1988 Ma CAHN
>A> AP 5GM/100ML;298MG/100ML;900MG/100M N19691 008 Mar 24, 1988 Ma CAHN
POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% IN SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;149MG/100ML;300MG/100M N18876 002 Jan 17, 1986 Ma CAHN
>A> HOSPIRA 5GM/100ML;149MG/100ML;300MG/100M N18876 002 Jan 17, 1986 Ma CAHN
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC
>D> ABBOTT 5GM/100ML;224MG/100ML;225MG/100M N18365 003 Jul 05, 1983 Ma CAHN
>A> HOSPIRA 5GM/100ML;224MG/100ML;225MG/100M N18365 003 Jul 05, 1983 Ma CAHN
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;224MG/100ML;300MG/100M N18876 003 Jan 17, 1986 Ma CAHN
>A> HOSPIRA 5GM/100ML;224MG/100ML;300MG/100M N18876 003 Jan 17, 1986 Ma CAHN
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;224MG/100ML;450MG/100M N18362 002 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;224MG/100ML;450MG/100M N18362 002 Ma CAHN
POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;224MG/100ML;900MG/100M N19691 007 Mar 24, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;224MG/100ML;900MG/100M N19691 007 Mar 24, 1988 Ma CAHN
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC
>D> ABBOTT 5GM/100ML;298MG/100ML;225MG/100M N18365 004 Jul 05, 1983 Ma CAHN
>A> HOSPIRA 5GM/100ML;298MG/100ML;225MG/100M N18365 004 Jul 05, 1983 Ma CAHN
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;298MG/100ML;300MG/100M N18876 004 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;298MG/100ML;300MG/100M N18876 004 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC
CONTAINER
>D> AP ABBOTT 5GM/100ML;298MG/100ML;450MG/100M N18362 003 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;298MG/100ML;450MG/100M N18362 003 Ma CAHN
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;298MG/100ML;900MG/100M N19691 009 Mar 24, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;298MG/100ML;900MG/100M N19691 009 Mar 24, 1988 Ma CAHN
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC
>D> ABBOTT 5GM/100ML;74.5MG/100ML;225MG/100ML N18365 005 Mar 28, 1988 Ma CAHN
>D> 5GM/100ML;149MG/100ML;225MG/100M N18365 007 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;74.5MG/100ML;225MG/100ML N18365 005 Mar 28, 1988 Ma CAHN
>A> 5GM/100ML;149MG/100ML;225MG/100M N18365 007 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC
>D> ABBOTT 5GM/100ML;74.5MG/100ML;300MG/100ML N18876 005 Mar 28, 1988 Ma CAHN
>D> 5GM/100ML;149MG/100ML;300MG/100M N18876 009 Mar 28, 1988 Ma CAHN
>A> HOSPIRA 5GM/100ML;74.5MG/100ML;300MG/100ML N18876 005 Mar 28, 1988 Ma CAHN
>A> 5GM/100ML;149MG/100ML;300MG/100M N18876 009 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;74.5MG/100ML;450MG/100ML N18362 008 Mar 28, 1988 Ma CAHN
>D> AP 5GM/100ML;149MG/100ML;450MG/100M N18362 004 Mar 28, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;74.5MG/100ML;450MG/100ML N18362 008 Mar 28, 1988 Ma CAHN
>A> AP 5GM/100ML;149MG/100ML;450MG/100M N18362 004 Mar 28, 1988 Ma CAHN
POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC
>D> AP ABBOTT 5GM/100ML;74.5MG/100ML;900MG/100ML N19691 001 Mar 24, 1988 Ma CAHN
>D> AP 5GM/100ML;149MG/100ML;900MG/100M N19691 003 Mar 24, 1988 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;74.5MG/100ML;900MG/100ML N19691 001 Mar 24, 1988 Ma CAHN
>A> AP 5GM/100ML;149MG/100ML;900MG/100M N19691 003 Mar 24, 1988 Ma CAHN
DEXTROSE; SODIUM CHLORIDE
INJECTABLE; INJECTION
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
>D> AP ABBOTT 2.5GM/100ML;450MG/100ML N18096 001 Ma CAHN
>A> AP HOSPIRA 2.5GM/100ML;450MG/100ML N18096 001 Ma CAHN
DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;225MG/100ML N17606 001 Ma CAHN
>A> HOSPIRA 5GM/100ML;225MG/100ML N17606 001 Ma CAHN
DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER
>D> ABBOTT 5GM/100ML;300MG/100ML N17799 001 Ma CAHN
>A> HOSPIRA 5GM/100ML;300MG/100ML N17799 001 Ma CAHN
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
>D> AP ABBOTT 5GM/100ML;450MG/100ML N17607 001 Ma CAHN
>A> AP HOSPIRA 5GM/100ML;450MG/100ML N17607 001 Ma CAHN
DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>D> AP ABBOTT 5GM/100ML;900MG/100ML N17585 001 Ma CAHN
>A> AP 5GM/100ML;900MG/100ML N17585 001 Ma CAHN
DIATRIZOATE MEGLUMINE
INJECTABLE; INJECTION
HYPAQUE
>D> AP + AMERSHAM HLTH 30% N16403 002 Ma DISC
>A> @ GE HEALTHCARE 30% N16403 002 Ma DISC
RENO-DIP
>D> AP + BRACCO 30% N10040 012 Ma CRLD
>A> + 30% N10040 012 Ma CRLD
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
INJECTABLE; INJECTION
>D> HYPAQUE-76
>D> AP AMERSHAM HLTH 66%;10% N86505 001 Ma DISC
>A> @ GE HEALTHCARE 66%;10% N86505 001 Ma DISC
DIAZEPAM
INJECTABLE; INJECTION
DIAZEPAM
>D> AP ABBOTT 5MG/ML N72079 001 Dec 20, 1988 Ma CAHN
>D> AP 5MG/ML N71584 001 Oct 13, 1987 Ma CAHN
>D> AP + 5MG/ML N71583 001 Oct 13, 1987 Ma CAHN
>A> AP HOSPIRA 5MG/ML N72079 001 Dec 20, 1988 Ma CAHN
>A> AP 5MG/ML N71584 001 Oct 13, 1987 Ma CAHN
>A> AP + 5MG/ML N71583 001 Oct 13, 1987 Ma CAHN
DIGOXIN
INJECTABLE; INJECTION
DIGOXIN
>D> AP ABBOTT 0.25MG/ML N40206 001 Aug 28, 1998 Ma CAHN
>D> AP 0.25MG/ML N40093 001 May 16, 1996 Ma CAHN
>A> AP HOSPIRA 0.25MG/ML N40206 001 Aug 28, 1998 Ma CAHN
>A> AP 0.25MG/ML N40093 001 May 16, 1996 Ma CAHN
DIGOXIN PEDIATRIC
>D> AP ABBOTT 0.1MG/ML N40092 001 Apr 25, 1996 Ma CAHN
>A> AP HOSPIRA 0.1MG/ML N40092 001 Apr 25, 1996 Ma CAHN
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
DILT-CD
>A> AB3 TORPHARM 120MG N76151 001 May 20, 2004 Ma NEWA
>A> AB3 180MG N76151 002 May 20, 2004 Ma NEWA
>A> AB3 240MG N76151 003 May 20, 2004 Ma NEWA
>A> AB3 300MG N76151 004 May 20, 2004 Ma NEWA
INJECTABLE; INJECTION
DILTIAZEM HCL
>D> AP ABBOTT 5MG/ML N75004 001 Feb 16, 2000 Ma CAHN
>D> AP 5MG/ML N74941 001 Apr 15, 1998 Ma CAHN
>D> AP 100MG/VIAL N75853 001 Dec 17, 2002 Ma CAHN
>A> AP HOSPIRA 5MG/ML N75004 001 Feb 16, 2000 Ma CAHN
>A> AP 5MG/ML N74941 001 Apr 15, 1998 Ma CAHN
>A> AP 100MG/VIAL N75853 001 Dec 17, 2002 Ma CAHN
DIPHENHYDRAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
DIPHENHYDRAMINE HCL
>D> AP ABBOTT 50MG/ML N40140 001 Nov 20, 1998 Ma CAHN
>A> AP HOSPIRA 50MG/ML N40140 001 Nov 20, 1998 Ma CAHN
DIPYRIDAMOLE
INJECTABLE; INJECTION
DIPYRIDAMOLE
>D> AP ABBOTT 5MG/ML N74601 001 Dec 19, 1997 Ma CAHN
>A> AP HOSPIRA 5MG/ML N74601 001 Dec 19, 1997 Ma CAHN
DOBUTAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
DOBUTAMINE HCL
>D> AP ABBOTT EQ 12.5MG BASE/ML N74292 001 Feb 16, 1995 Ma CAHN
>D> AP EQ 12.5MG BASE/ML N74086 001 Nov 29, 1993 Ma CAHN
>D> AP EQ 1.25GM BASE/100ML N74634 001 Sep 27, 1996 Ma CAHN
>A> AP HOSPIRA EQ 12.5MG BASE/ML N74292 001 Feb 16, 1995 Ma CAHN
>A> AP EQ 12.5MG BASE/ML N74086 001 Nov 29, 1993 Ma CAHN
>A> AP EQ 1.25GM BASE/100ML N74634 001 Sep 27, 1996 Ma CAHN
DOBUTAMINE HCL IN DEXTROSE 5%
>D> AP + ABBOTT EQ 50MG BASE/100ML N20269 001 Oct 19, 1993 Ma CAHN
>D> AP + EQ 100MG BASE/100ML N20269 002 Oct 19, 1993 Ma CAHN
>D> AP + EQ 200MG BASE/100ML N20269 003 Oct 19, 1993 Ma CAHN
>A> AP + HOSPIRA EQ 50MG BASE/100ML N20269 001 Oct 19, 1993 Ma CAHN
>A> AP + EQ 100MG BASE/100ML N20269 002 Oct 19, 1993 Ma CAHN
>A> AP + EQ 200MG BASE/100ML N20269 003 Oct 19, 1993 Ma CAHN
DOBUTAMINE HCL IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP + ABBOTT EQ 50MG BASE/100ML N20201 003 Oct 19, 1993 Ma CAHN
>D> AP + EQ 100MG BASE/100ML N20201 002 Oct 19, 1993 Ma CAHN
>D> AP + EQ 200MG BASE/100ML N20201 001 Oct 19, 1993 Ma CAHN
>D> AP + EQ 400MG BASE/100ML N20201 006 Jul 07, 1994 Ma CAHN
>A> AP + HOSPIRA EQ 50MG BASE/100ML N20201 003 Oct 19, 1993 Ma CAHN
>A> AP + EQ 100MG BASE/100ML N20201 002 Oct 19, 1993 Ma CAHN
>A> AP + EQ 200MG BASE/100ML N20201 001 Oct 19, 1993 Ma CAHN
>A> AP + EQ 400MG BASE/100ML N20201 006 Jul 07, 1994 Ma CAHN
DOPAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
DOPAMINE HCL
>D> AP ABBOTT 40MG/ML N74403 001 May 23, 1996 Ma CAHN
>D> AP + 40MG/ML N18132 001 Ma CAHN
>D> AP + ABBOTT 80MG/100ML N18132 002 Feb 04, 1982 Ma CAHN
>D> AP + 80MG/ML N18132 004 Jul 09, 1982 Ma CAHN
>D> AP + 160MG/100ML N18132 003 Feb 04, 1982 Ma CAHN
>A> AP HOSPIRA 40MG/ML N74403 001 May 23, 1996 Ma CAHN
>A> AP + 40MG/ML N18132 001 Ma CAHN
>A> AP + 80MG/100ML N18132 002 Feb 04, 1982 Ma CAHN
>A> AP + 80MG/ML N18132 004 Jul 09, 1982 Ma CAHN
>A> AP + 160MG/100ML N18132 003 Feb 04, 1982 Ma CAHN
DOPAMINE HCL IN DEXTROSE 5%
>D> AP + ABBOTT 1.6MG/ML N20542 001 Aug 30, 1995 Ma CAHN
>A> AP + HOSPIRA 1.6MG/ML N20542 001 Aug 30, 1995 Ma CAHN
DOPAMINE HCL IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP + ABBOTT 80MG/100ML N18826 001 Sep 30, 1983 Ma CAHN
>D> AP + 160MG/100ML N18826 002 Sep 30, 1983 Ma CAHN
>D> AP + 320MG/100ML N18826 003 Sep 30, 1983 Ma CAHN
>A> AP + HOSPIRA 80MG/100ML N18826 001 Sep 30, 1983 Ma CAHN
>A> AP + 160MG/100ML N18826 002 Sep 30, 1983 Ma CAHN
>A> AP + 320MG/100ML N18826 003 Sep 30, 1983 Ma CAHN
DROPERIDOL
INJECTABLE; INJECTION
DROPERIDOL
>D> AP ABBOTT 2.5MG/ML N72272 001 Aug 31, 1995 Ma CAHN
>D> AP 2.5MG/ML N71981 001 Feb 29, 1988 Ma CAHN
>A> AP HOSPIRA 2.5MG/ML N72272 001 Aug 31, 1995 Ma CAHN
>A> AP 2.5MG/ML N71981 001 Feb 29, 1988 Ma CAHN
DROPERIDOL; FENTANYL CITRATE
INJECTABLE; INJECTION
FENTANYL CITRATE AND DROPERIDOL
>D> + ABBOTT 2.5MG/ML;EQ 0.05MG BASE/ML N71982 001 May 04, 1988 Ma CAHN
>A> + HOSPIRA 2.5MG/ML;EQ 0.05MG BASE/ML N71982 001 May 04, 1988 Ma CAHN
EDETATE DISODIUM
INJECTABLE; INJECTION
ENDRATE
>D> AP + ABBOTT 150MG/ML N11355 001 Ma CAHN
>A> AP + HOSPIRA 150MG/ML N11355 001 Ma CAHN
EDROPHONIUM CHLORIDE
INJECTABLE; INJECTION
EDROPHONIUM CHLORIDE
>D> AP ABBOTT 10MG/ML N40131 001 Feb 24, 1998 Ma CAHN
>A> AP HOSPIRA 10MG/ML N40131 001 Feb 24, 1998 Ma CAHN
ENALAPRILAT
INJECTABLE; INJECTION
ENALAPRILAT
>D> AP ABBOTT 1.25MG/ML N75458 001 Aug 22, 2000 Ma CAHN
>D> AP 1.25MG/ML N75456 001 Aug 22, 2000 Ma CAHN
>A> AP HOSPIRA 1.25MG/ML N75458 001 Aug 22, 2000 Ma CAHN
>A> AP 1.25MG/ML N75456 001 Aug 22, 2000 Ma CAHN
EPINEPHRINE
INJECTABLE; INTRAMUSCULAR, SUBCUTANEOUS
>A> EPINEPHRINE
>A> + HOLLISTER STIER EQ 0.15MG /DELIVERY N20800 002 May 28, 2004 Ma NEWA
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
LIDOCAINE HCL AND EPINEPHRINE
>D> AP ABBOTT 0.005MG/ML;0.5% N89635 001 Jun 21, 1988 Ma CAHN
>D> AP 0.005MG/ML;1% N89649 001 Jun 21, 1988 Ma CAHN
>D> AP 0.005MG/ML;1.5% N89650 001 Jun 21, 1988 Ma CAHN
>D> AP 0.005MG/ML;1.5% N89645 001 Jun 21, 1988 Ma CAHN
>D> AP 0.005MG/ML;1.5% N88571 001 Sep 13, 1985 Ma CAHN
>D> AP 0.005MG/ML;2% N89651 001 Jun 21, 1988 Ma CAHN
>D> AP 0.01MG/ML;1% N89644 001 Jun 21, 1988 Ma CAHN
>D> AP 0.01MG/ML;2% N89646 001 Jun 21, 1988 Ma CAHN
>A> AP HOSPIRA 0.005MG/ML;0.5% N89635 001 Jun 21, 1988 Ma CAHN
>A> AP HOSPIRA 0.005MG/ML;1% N89649 001 Jun 21, 1988 Ma CAHN
>A> AP 0.005MG/ML;1.5% N89650 001 Jun 21, 1988 Ma CAHN
>A> AP 0.005MG/ML;1.5% N89645 001 Jun 21, 1988 Ma CAHN
>A> AP 0.005MG/ML;1.5% N88571 001 Sep 13, 1985 Ma CAHN
>A> AP 0.005MG/ML;2% N89651 001 Jun 21, 1988 Ma CAHN
>A> AP 0.01MG/ML;1% N89644 001 Jun 21, 1988 Ma CAHN
>A> AP 0.01MG/ML;2% N89646 001 Jun 21, 1988 Ma CAHN
>A> PATCH; IONTOPHORESIS
>A> LIDOSITE TOPICAL SYSTEM KIT
>A> + VYTERIS 1.05MG/PATCH;100MG/PATCH N21504 001 May 06, 2004 Ma NEWA
ERYTHROMYCIN LACTOBIONATE
INJECTABLE; INJECTION
ERYTHROCIN
>D> AP ABBOTT EQ 500MG BASE/VIAL N62638 001 Oct 31, 1986 Ma CAHN
>D> AP EQ 500MG BASE/VIAL N50609 001 Sep 24, 1986 Ma CAHN
>D> AP + EQ 500MG BASE/VIAL N50182 002 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N62638 002 Oct 31, 1986 Ma CAHN
>D> AP EQ 1GM BASE/VIAL N50609 002 Sep 24, 1986 Ma CAHN
>D> AP + EQ 1GM BASE/VIAL N50182 003 Ma CAHN
>A> AP HOSPIRA EQ 500MG BASE/VIAL N62638 001 Oct 31, 1986 Ma CAHN
>A> AP EQ 500MG BASE/VIAL N50609 001 Sep 24, 1986 Ma CAHN
>A> AP + EQ 500MG BASE/VIAL N50182 002 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N62638 002 Oct 31, 1986 Ma CAHN
>A> AP EQ 1GM BASE/VIAL N50609 002 Sep 24, 1986 Ma CAHN
>A> AP + EQ 1GM BASE/VIAL N50182 003 Ma CAHN
ESTRADIOL ACETATE
INSERT, EXTENDED RELEASE; VAGINAL
FEMRING
>D> GALEN LTD 0.05MG/24HR N21367 001 Mar 20, 2003 Ma CPOT
>A> EQ 0.05MG BASE/24HR N21367 001 Mar 20, 2003 Ma CPOT
>D> + 0.1MG/24HR N21367 002 Mar 20, 2003 Ma CPOT
>A> + EQ 0.1MG BASE/24HR N21367 002 Mar 20, 2003 Ma CPOT
ESTROGENS, CONJUGATED
TABLET; ORAL
PREMARIN
>D> WYETH PHARMS INC 2.5MG N04782 002 Ma DISC
>A> @ 2.5MG N04782 002 Ma DISC
>A> ESTROGENS, CONJUGATED SYNTHETIC B
>A> TABLET; ORAL
>A> ENJUVIA
>A> DURAMED 0.625MG N21443 003 May 10, 2004 Ma NEWA
>A> + 1.25MG N21443 004 May 10, 2004 Ma NEWA
ETHAMBUTOL HYDROCHLORIDE
TABLET; ORAL
MYAMBUTOL
>D> @ ELAN PHARMS 100MG N16320 001 Ma CMFD
>D> @ 200MG N16320 002 Ma CAHN
>D> @ 400MG N16320 003 Ma CMFD
>D> @ 500MG N16320 004 Ma CAHN
>A> AB STAT TRADE 100MG N16320 001 Ma CMFD
>A> @ 200MG N16320 002 Ma CAHN
>A> AB 400MG N16320 003 Ma CMFD
>A> @ 500MG N16320 004 Ma CAHN
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET; ORAL-21
LEVLITE
>D> AB + BERLEX 0.02MG;0.1MG N20860 001 Jul 13, 1998 Ma CTEC
>A> AB2 + 0.02MG;0.1MG N20860 001 Jul 13, 1998 Ma CTEC
TABLET; ORAL-28
LESSINA-28
>D> AB BARR 0.02MG;0.1MG N75803 002 Mar 20, 2002 Ma CTEC
>A> AB2 0.02MG;0.1MG N75803 002 Mar 20, 2002 Ma CTEC
LEVLITE
>D> AB BERLEX 0.02MG;0.1MG N20860 002 Jul 13, 1998 Ma CTEC
>A> AB2 BERLEX 0.02MG;0.1MG N20860 002 Jul 13, 1998 Ma CTEC
ETODOLAC
TABLET, EXTENDED RELEASE; ORAL
LODINE XL
>D> AB + WYETH PHARMS INC 400MG N20584 001 Oct 25, 1996 Ma CRLD
>A> AB 400MG N20584 001 Oct 25, 1996 Ma CRLD
>D> AB + 500MG N20584 003 Jan 20, 1998 Ma CRLD
>A> AB 500MG N20584 003 Jan 20, 1998 Ma CRLD
ETOMIDATE
INJECTABLE; INJECTION
AMIDATE
>D> AP + ABBOTT 2MG/ML N18227 001 Sep 07, 1982 Ma CAHN
>A> AP + HOSPIRA 2MG/ML N18227 001 Sep 07, 1982 Ma CAHN
ETOPOSIDE
INJECTABLE; INJECTION
ETOPOSIDE
>D> AP ABBOTT 20MG/ML N74351 001 Aug 30, 1995 Ma CAHN
>D> AP 20MG/ML N74320 001 Aug 30, 1995 Ma CAHN
>A> AP HOSPIRA 20MG/ML N74351 001 Aug 30, 1995 Ma CAHN
>A> AP 20MG/ML N74320 001 Aug 30, 1995 Ma CAHN
FAMOTIDINE
INJECTABLE; INJECTION
FAMOTIDINE
>D> AP ABBOTT 10MG/ML N75905 001 Nov 23, 2001 Ma CAHN
>D> AP 10MG/ML N75870 001 Nov 23, 2001 Ma CAHN
>A> AP HOSPIRA 10MG/ML N75905 001 Nov 23, 2001 Ma CAHN
>A> AP 10MG/ML N75870 001 Nov 23, 2001 Ma CAHN
FENOLDOPAM MESYLATE
INJECTABLE; INJECTION
CORLOPAM
>D> AP + ABBOTT EQ 10MG BASE/ML N19922 001 Sep 23, 1997 Ma CAHN
>A> AP + HOSPIRA EQ 10MG BASE/ML N19922 001 Sep 23, 1997 Ma CAHN
FENTANYL CITRATE
INJECTABLE; INJECTION
FENTANYL CITRATE
>D> AP ABBOTT EQ 0.05MG BASE/ML N19115 001 Jan 12, 1985 Ma CAHN
>A> AP HOSPIRA EQ 0.05MG BASE/ML N19115 001 Jan 12, 1985 Ma CAHN
FENTANYL CITRATE PRESERVATIVE FREE
>D> AP ABBOTT EQ 0.05MG BASE/ML N72786 001 Sep 24, 1991 Ma CAHN
>A> AP HOSPIRA EQ 0.05MG BASE/ML N72786 001 Sep 24, 1991 Ma CAHN
>D> FLUDEOXYGLUCOSE, F-18
>D> INJECTABLE; INJECTION
>D> FLUDEOXYGLUCOSE F 18
>D> + DOWNSTATE CLINCL 4-90mCi/ML N20306 002 Sep 25, 2001 Ma DISC
>A> @ 4-90mCi/ML N20306 002 Sep 25, 2001 Ma DISC
FLUOXETINE HYDROCHLORIDE
SOLUTION; ORAL
FLUOXETINE HCL
>A> AA PAR PHARM EQ 20MG BASE/5ML N76458 001 May 14, 2004 Ma NEWA
FLUTICASONE PROPIONATE
AEROSOL, METERED; INHALATION
>A> FLOVENT HFA
>A> GLAXOSMITHKLINE 0.044MG/INH N21433 003 May 14, 2004 Ma NEWA
>A> 0.11MG/INH |
